{"id":6286,"date":"2025-04-06T11:44:54","date_gmt":"2025-04-06T08:44:54","guid":{"rendered":"https:\/\/jordan-cardiac.org\/?p=6286"},"modified":"2025-04-06T11:44:54","modified_gmt":"2025-04-06T08:44:54","slug":"efficacy-of-rivaroxaban-versus-warfarin-in-patients-with-acute-left-ventricular-thrombus-following-myocardial-infarction-rivawar-trial","status":"publish","type":"post","link":"https:\/\/jordan-cardiac.org\/en\/efficacy-of-rivaroxaban-versus-warfarin-in-patients-with-acute-left-ventricular-thrombus-following-myocardial-infarction-rivawar-trial\/","title":{"rendered":"Efficacy Of Rivaroxaban Versus Warfarin In Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR Trial"},"content":{"rendered":"<div>Efficacy Of Rivaroxaban Versus Warfarin In Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR Trial:<\/div>\n<div><\/div>\n<div>Presenter: Jehangir Shah, MD (Karachi, Pakistan)<\/div>\n<div>Date: March 2025<\/div>\n<div>Reference:\u00a0 ACC.25 Scientific Session.<\/div>\n<div><\/div>\n<div>Key Points Summary<\/div>\n<div><span> 1. Study Background:<\/span><\/div>\n<div>The RIVAWAR trial evaluated rivaroxaban versus warfarin for treatment of left ventricular thrombus (LVT) in patients post-myocardial infarction (MI), a condition traditionally treated with VKAs like warfarin.<\/div>\n<div><span> 2. Methods:<\/span><\/div>\n<div><span> \u2022 Phase 4, single-center, open-label RCT<\/span><\/div>\n<div><span> \u2022 261 patients with post-MI LVT<\/span><\/div>\n<div><span> \u2022 Randomized 2:1 to rivaroxaban 20 mg daily or warfarin (target INR 2\u20133) for 3 months<\/span><\/div>\n<div><span> \u2022 Primary endpoint: LVT resolution on echocardiography<\/span><\/div>\n<div><span> \u2022 Secondary endpoints: all-cause mortality, MI, stroke, major bleeding<\/span><\/div>\n<div><span> 3. Main Results:<\/span><\/div>\n<div><span> \u2022 At 1 month: LVT resolution occurred in 20.1% (rivaroxaban) vs. 8.3% (warfarin)<\/span><\/div>\n<div><span> \u2022 At 3 months: LVT resolution in 95.8% (rivaroxaban) vs. 96.6% (warfarin)<\/span><\/div>\n<div><span> \u2022 No significant difference in secondary outcomes: mortality, stroke, or bleeding<\/span><\/div>\n<div><span> 4. Conclusion:<\/span><\/div>\n<div>Rivaroxaban was as effective as warfarin in resolving LVT by 3 months, with comparable safety. These results suggest rivaroxaban is a practical alternative to warfarin, especially considering ease of use and no need for INR monitoring.<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Efficacy Of Rivaroxaban Versus Warfarin In Patients With Acute Left Ventricular Thrombus Following Myocardial Infarction: RIVAWAR Trial: Presenter: Jehangir Shah, MD (Karachi, Pakistan) Date: March 2025 Reference:\u00a0 ACC.25 Scientific Session. Key Points Summary 1. Study Background: The RIVAWAR trial evaluated rivaroxaban versus warfarin for treatment of left ventricular thrombus (LVT) in patients post-myocardial infarction (MI), [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-6286","post","type-post","status-publish","format-standard","hentry","category-uncategorized"],"_links":{"self":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6286","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/comments?post=6286"}],"version-history":[{"count":1,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6286\/revisions"}],"predecessor-version":[{"id":6288,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/posts\/6286\/revisions\/6288"}],"wp:attachment":[{"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/media?parent=6286"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/categories?post=6286"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/jordan-cardiac.org\/en\/wp-json\/wp\/v2\/tags?post=6286"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}